Renatus Meditech Solutions Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 30-12-2024
- Paid Up Capital ₹ 0.10 M
as on 30-12-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 6950.71%
(FY 2022)
- Profit -281.03%
(FY 2022)
- Ebitda -231.86%
(FY 2022)
- Net Worth -406.39%
(FY 2022)
- Total Assets 606.24%
(FY 2022)
About Renatus Meditech Solutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Gupta and Nipur Gupta serve as directors at the Company.
- CIN/LLPIN
U74999CH2020PTC042994
- Company No.
042994
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Renatus Meditech Solutions?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Gupta  | Director | 23-May-2020 | Current |
| Nipur Gupta | Director | 04-Jan-2023 | Current |
Financial Performance of Renatus Meditech Solutions.
Renatus Meditech Solutions Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 6950.71% increase. The company also saw a substantial fall in profitability, with a 281.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 406.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Renatus Meditech Solutions?
In 2022, Renatus Meditech Solutions had a promoter holding of 29.15% and a public holding of 70.85%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Recorders & Medicare Systems Private LimitedActive 21 years 16 daysNeeraj Gupta and Nipur Gupta are mutual person
- Rn Chemicals & Pharmaceutical Private LimitedActive 6 years 4 months
Neeraj Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Renatus Meditech Solutions?
Renatus Meditech Solutions has a workforce of 11 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renatus Meditech Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renatus Meditech Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
